Procyte Dx Maintenance Agreement
IDEXX VetLab Suite includes instrument systems and associated consumables. In addition, the company offers maintenance contracts related to the sale of its instruments. The company sells three chemical analyzers, the Catalyst Dx Chemistry Analyzer, the Catalyst One Chemistry Analyzer and the VetTest Chemistry Analyzer, used by veterinarians to measure the content of certain enzymes and other substances in the blood or urine, to monitor health status and assist in the diagnosis of physiological conditions. The Catalyst Dx analyzer allows a veterinarian to perform multiple patient samples at once and catalyst Dx and Catalyst One perform different types of samples, including total blood, plasma, serum and urine. In addition, Catalyst Dx and Catalyst One analyzers perform a test to measure phenobarbital levels in the blood so that veterinarians can adjust seizures. The company also owns two other chemical analyzers, the VetLyte Electrolyte Analyzer and the VetStat Electrolyte and Blood Gas Analyzer. The VetStat analyzer operates disposable cassettes manufactured by OPTI Medical. This press release contains or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of words such as „expected,” „may,” „expected,” „would,” „would,” „plans,” „thinks,” „estimates,” „should,” „project” and similar words and phrases.
These forward-looking statements are intended to provide our current expectations or forecasts for future events; Are based on current estimates, projections, beliefs and assumptions; and are not guarantees for future benefits. Actual events or results may differ materially from those described in the forward-looking statements, as well as a series of assumptions about future events. These statements are subject to risks, uncertainties, assumptions and other important factors. Readers are cautioned not to improperly rely on such forward-looking statements, as actual results may differ materially from those expressed or implied. IDEXX`s reports under U.S. securities law contain discussions on some of these risks and uncertainties. IDEXX undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or other information, and expressly refuses to update or revise any forward-looking statements. Readers are advised to check IDEXX`s registrations with the United States Securities and Exchange Commission (available in the SEC`s EDGAR database under sec.gov and on the IDEXX website at idexx.com). The CAG segment provides veterinarians with diagnostic functions and information management solutions that manage the health and well-being of pets. The company offers diagnostic skills that meet the needs of veterinarians through a number of modalities, including clinical diagnostic solutions and external reference laboratory services. Regardless of the method used, veterinarians receive clinically relevant data that is integrated into their information management technologies.
VetConnect PLUS is a cloud-based technology that allows veterinarians to access and analyze patient data from all their diagnostic modalities. In addition, VetConnect PLUS provides mobile or browser-based access to results that can be printed or emailed to pet owners and other veterinarians. Diagnostic solutions at the clinic are composed of the IDEXX VetLab suite in clinical chemistry, Hematology, immunology, urine analysis and clotting analysis, associated consumables that provide real-time diagnostic results in real time in the reference laboratory, and a set of hand-guided IDEXX SNAP rapid test kits that provide point-of-care diagnostic results for a number of animal diseases and associated health conditions.